Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Improving the Accuracy of Scores to Predict Gastrostomy after Intracerebral Hemorrhage with Machine Learning.

Garg R, Prabhakaran S, Holl JL, Luo Y, Faigle R, Kording K, Naidech AM.

J Stroke Cerebrovasc Dis. 2018 Sep 7. pii: S1052-3057(18)30468-3. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.026. [Epub ahead of print]

PMID:
30201458
2.

Delirium Monitoring in Neurocritically Ill Patients: A Systematic Review.

Patel MB, Bednarik J, Lee P, Shehabi Y, Salluh JI, Slooter AJ, Klein KE, Skrobik Y, Morandi A, Spronk PE, Naidech AM, Pun BT, Bozza FA, Marra A, John S, Pandharipande PP, Ely EW.

Crit Care Med. 2018 Nov;46(11):1832-1841. doi: 10.1097/CCM.0000000000003349.

PMID:
30142098
3.

Assessment and comparison of the max-ICH score and ICH score by external validation.

Schmidt FA, Liotta EM, Prabhakaran S, Naidech AM, Maas MB.

Neurology. 2018 Sep 4;91(10):e939-e946. doi: 10.1212/WNL.0000000000006117. Epub 2018 Aug 1.

PMID:
30068631
4.

Prophylactic Seizure Medication and Health-Related Quality of Life After Intracerebral Hemorrhage.

Naidech AM, Beaumont J, Muldoon K, Liotta EM, Maas MB, Potts MB, Jahromi BS, Cella D, Prabhakaran S, Holl JL.

Crit Care Med. 2018 Sep;46(9):1480-1485. doi: 10.1097/CCM.0000000000003272.

PMID:
29923930
5.

Fever Burden and Health-Related Quality of Life After Intracerebral Hemorrhage.

Bush RA, Beaumont JL, Liotta EM, Maas MB, Naidech AM.

Neurocrit Care. 2018 Oct;29(2):189-194. doi: 10.1007/s12028-018-0523-y.

PMID:
29600341
6.

Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic Encephalopathy.

Liotta EM, Romanova AL, Lizza BD, Rasmussen-Torvik LJ, Kim M, Francis B, Sangha RS, Carroll TJ, Ganger D, Ladner DP, Naidech AM, Paparello JJ, Prabhakaran S, Sorond FA, Maas MB.

Crit Care Med. 2018 Feb;46(2):280-289. doi: 10.1097/CCM.0000000000002831.

PMID:
29341965
7.

Medication History versus Point-of-Care Platelet Activity Testing in Patients with Intracerebral Hemorrhage.

Maas MB, Naidech AM, Kim M, Batra A, Manno EM, Sorond FA, Prabhakaran S, Liotta EM.

J Stroke Cerebrovasc Dis. 2018 May;27(5):1167-1173. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.033. Epub 2018 Jan 5.

PMID:
29310956
8.

Impact of Multiple Daily Clinical Pharmacist-Enforced Assessments on Time in Target Sedation Range.

Lizza BD, Jagow B, Hensler D, Cooper CJ, Short EJ, Maas MB, Naidech AM, Wunderink RG.

J Pharm Pract. 2018 Oct;31(5):445-449. doi: 10.1177/0897190017729522. Epub 2017 Sep 6.

PMID:
28874082
9.

Author response: Evolving use of seizure medications after intracerebral hemorrhage: A multicenter study.

Naidech AM, Jahromi B, Prabhakaran S, Holl JL.

Neurology. 2017 Aug 1;89(5):520. doi: 10.1212/WNL.0000000000004192. No abstract available.

PMID:
28760915
10.

Magnesium, hemostasis, and outcomes in patients with intracerebral hemorrhage.

Liotta EM, Prabhakaran S, Sangha RS, Bush RA, Long AE, Trevick SA, Potts MB, Jahromi BS, Kim M, Manno EM, Sorond FA, Naidech AM, Maas MB.

Neurology. 2017 Aug 22;89(8):813-819. doi: 10.1212/WNL.0000000000004249. Epub 2017 Jul 26.

11.

Challenges in the Medical Management of Symptomatic Intracranial Stenosis in an Urban Setting.

Sangha RS, Naidech AM, Corado C, Ansari SA, Prabhakaran S.

Stroke. 2017 Aug;48(8):2158-2163. doi: 10.1161/STROKEAHA.116.016254. Epub 2017 Jul 5.

12.

Disparities in the Use of Seizure Medications After Intracerebral Hemorrhage.

Naidech AM, Toledo P, Prabhakaran S, Holl JL.

Stroke. 2017 Mar;48(3):802-804. doi: 10.1161/STROKEAHA.116.015779. Epub 2017 Jan 19.

13.

Refining Prognosis for Intracerebral Hemorrhage by Early Reassessment.

Maas MB, Francis BA, Sangha RS, Lizza BD, Liotta EM, Naidech AM.

Cerebrovasc Dis. 2017;43(3-4):110-116. doi: 10.1159/000452679. Epub 2017 Jan 4.

14.

Critical Care Neurology Perspective on Delirium.

Maas MB, Naidech AM.

Semin Neurol. 2016 Dec;36(6):601-606. Epub 2016 Dec 1. Review.

PMID:
27907964
15.

Evolving use of seizure medications after intracerebral hemorrhage: A multicenter study.

Naidech AM, Beaumont J, Jahromi B, Prabhakaran S, Kho A, Holl JL.

Neurology. 2017 Jan 3;88(1):52-56. doi: 10.1212/WNL.0000000000003461. Epub 2016 Nov 18.

16.

Agitation, Delirium, and Cognitive Outcomes in Intracerebral Hemorrhage.

Rosenthal LJ, Francis BA, Beaumont JL, Cella D, Berman MD, Maas MB, Liotta EM, Askew R, Naidech AM.

Psychosomatics. 2017 Jan - Feb;58(1):19-27. doi: 10.1016/j.psym.2016.07.004. Epub 2016 Aug 5.

17.

Quality of life in patients with TIA and minor ischemic stroke.

Sangha RS, Caprio FZ, Askew R, Corado C, Bernstein R, Curran Y, Ruff I, Cella D, Naidech AM, Prabhakaran S.

Neurology. 2015 Dec 1;85(22):1957-63. doi: 10.1212/WNL.0000000000002164. Epub 2015 Nov 4.

18.

Hematoma Locations Predicting Delirium Symptoms After Intracerebral Hemorrhage.

Naidech AM, Polnaszek KL, Berman MD, Voss JL.

Neurocrit Care. 2016 Jun;24(3):397-403. doi: 10.1007/s12028-015-0210-1.

19.

Diagnosis and Management of Spontaneous Intracerebral Hemorrhage.

Naidech AM.

Continuum (Minneap Minn). 2015 Oct;21(5 Neurocritical Care):1288-98. doi: 10.1212/CON.0000000000000222. Review.

PMID:
26426231
20.

Neuro-Intensivists as Effective Resource Managers. No, Really.

Naidech AM.

Neurocrit Care. 2015 Dec;23(3):305-6. doi: 10.1007/s12028-015-0197-7. No abstract available.

PMID:
26319045
21.

23.4% Saline Decreases Brain Tissue Volume in Severe Hepatic Encephalopathy as Assessed by a Quantitative CT Marker.

Liotta EM, Lizza BD, Romanova AL, Guth JC, Berman MD, Carroll TJ, Francis B, Ganger D, Ladner DP, Maas MB, Naidech AM.

Crit Care Med. 2016 Jan;44(1):171-9. doi: 10.1097/CCM.0000000000001276.

22.

The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms.

Reynolds MR, Buckley RT, Indrakanti SS, Turkmani AH, Oh G, Crobeddu E, Fargen KM, El Ahmadieh TY, Naidech AM, Amin-Hanjani S, Lanzino G, Hoh BL, Bendok BR, Zipfel GJ.

J Neurosurg. 2015 Oct;123(4):862-71. doi: 10.3171/2014.12.JNS141201. Epub 2015 Jul 24.

PMID:
26207606
23.

Impact of Poststroke Medical Complications on 30-Day Readmission Rate.

Shah SV, Corado C, Bergman D, Curran Y, Bernstein RA, Naidech AM, Prabhakaran S.

J Stroke Cerebrovasc Dis. 2015 Sep;24(9):1969-77. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.037. Epub 2015 Jul 10.

PMID:
26166419
24.

Neurochecks as a Biomarker of the Temporal Profile and Clinical Impact of Neurologic Changes after Intracerebral Hemorrhage.

Maas MB, Berman MD, Guth JC, Liotta EM, Prabhakaran S, Naidech AM.

J Stroke Cerebrovasc Dis. 2015 Sep;24(9):2026-31. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.045. Epub 2015 Jul 2.

25.

Dichotomous "Good Outcome" Indicates Mobility More Than Cognitive or Social Quality of Life.

Naidech AM, Beaumont JL, Berman M, Francis B, Liotta E, Maas MB, Prabhakaran S, Holl J, Cella D.

Crit Care Med. 2015 Aug;43(8):1654-9. doi: 10.1097/CCM.0000000000001082.

26.

Reversal of the novel oral anticoagulants dabigatran, rivoraxaban, and apixaban.

Liotta EM, Levasseur-Franklin KE, Naidech AM.

Curr Opin Crit Care. 2015 Apr;21(2):127-33. doi: 10.1097/MCC.0000000000000181. Review.

PMID:
25689124
27.

Acute changes in ventricular volume during treatment for hepatic and renal failure.

Liotta EM, Bauer RM, Berman MD, Guth JC, Maas MB, Naidech AM, Rosenberg NF.

Neurol Clin Pract. 2014 Dec;4(6):478-481. No abstract available.

28.

Web-Based Assessment of Outcomes After Subarachnoid and Intracerebral Hemorrhage: A New Patient Centered Option for Outcomes Assessment.

Naidech AM, Beaumont JL, Berman M, Liotta E, Maas MB, Prabhakaran S, Kording K, Holl J, Cella D.

Neurocrit Care. 2015 Aug;23(1):22-7. doi: 10.1007/s12028-014-0098-1.

PMID:
25510897
29.

Monitoring of hematological and hemostatic parameters in neurocritical care patients.

Naidech AM, Kumar MA; Participants in the International Multidisciplinary Consensus Conference on Multimodality Monitoring.

Neurocrit Care. 2014 Dec;21 Suppl 2:S168-76. doi: 10.1007/s12028-014-0023-7. Review.

PMID:
25208669
30.

Subarachnoid extension of hemorrhage is associated with early seizures in primary intracerebral hemorrhage.

Guth JC, Gerard EE, Nemeth AJ, Liotta EM, Prabhakaran S, Naidech AM, Maas MB.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2809-13. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.023. Epub 2014 Sep 4.

PMID:
25194742
31.

Magnetic resonance imaging versus computed tomography for identification and quantification of intraventricular hemorrhage.

Romanova AL, Nemeth AJ, Berman MD, Guth JC, Liotta EM, Naidech AM, Maas MB.

J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2036-2040. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.005. Epub 2014 Jul 30.

32.

Desmopressin improves platelet activity in acute intracerebral hemorrhage.

Naidech AM, Maas MB, Levasseur-Franklin KE, Liotta EM, Guth JC, Berman M, Rosenow JM, Lindholm PF, Bendok BR, Prabhakaran S, Bernstein RA, Kwaan HC.

Stroke. 2014 Aug;45(8):2451-3. doi: 10.1161/STROKEAHA.114.006061. Epub 2014 Jul 8.

33.

Pearls & oy-sters: bilateral thalamic involvement in West Nile virus encephalitis.

Guth JC, Futterer SA, Hijaz TA, Liotta EM, Rosenberg NF, Naidech AM, Maas MB.

Neurology. 2014 Jul 8;83(2):e16-7. doi: 10.1212/WNL.0000000000000571. No abstract available.

34.

Preadmission statin use does not improve functional outcomes or prevent delayed ischemic events in patients with spontaneous subarachnoid hemorrhage.

Lizza BD, Kosteva A, Maas MB, Rosenberg NF, Liotta E, Guth J, Levasseur-Franklin KE, Naidech AM.

Pharmacotherapy. 2014 Aug;34(8):811-7. doi: 10.1002/phar.1436. Epub 2014 May 7.

PMID:
24807391
35.

Subarachnoid extension of primary intracerebral hemorrhage is associated with fevers.

Guth JC, Nemeth AJ, Rosenberg NF, Kosteva AR, Bauer RM, Liotta EM, Prabhakaran S, Naidech AM, Maas MB.

Neurocrit Care. 2014 Apr;20(2):187-92. doi: 10.1007/s12028-013-9888-0.

PMID:
24186539
36.

Predictors of intraventricular extension of intracerebral hemorrhage confounded by antithrombotic medication exposure.

Maas MB, Caprio FZ, Rosenberg NF, Naidech AM.

Crit Care Med. 2013 Nov;41(11):e394. doi: 10.1097/CCM.0b013e3182a11e81. No abstract available.

37.

Intracerebral hemorrhage and delirium symptoms. Length of stay, function, and quality of life in a 114-patient cohort.

Naidech AM, Beaumont JL, Rosenberg NF, Maas MB, Kosteva AR, Ault ML, Cella D, Ely EW.

Am J Respir Crit Care Med. 2013 Dec 1;188(11):1331-7. doi: 10.1164/rccm.201307-1256OC.

38.

Predictors of 30-day readmission after subarachnoid hemorrhage.

Singh M, Guth JC, Liotta E, Kosteva AR, Bauer RM, Prabhakaran S, Rosenberg N, Bendok BR, Maas MB, Naidech AM.

Neurocrit Care. 2013 Dec;19(3):306-10. doi: 10.1007/s12028-013-9908-0.

PMID:
24037248
39.

Predictors of 30-day readmission after intracerebral hemorrhage: a single-center approach for identifying potentially modifiable associations with readmission.

Liotta EM, Singh M, Kosteva AR, Beaumont JL, Guth JC, Bauer RM, Prabhakaran S, Rosenberg NF, Maas MB, Naidech AM.

Crit Care Med. 2013 Dec;41(12):2762-9. doi: 10.1097/CCM.0b013e318298a10f.

40.

Infarct volume predicts delayed recovery in patients with subarachnoid hemorrhage and severe neurological deficits.

Rosenberg NF, Liebling SM, Kosteva AR, Maas MB, Prabhakaran S, Naidech AM.

Neurocrit Care. 2013 Dec;19(3):293-8. doi: 10.1007/s12028-013-9869-3.

PMID:
23860664
41.

Surveillance neuroimaging and neurologic examinations affect care for intracerebral hemorrhage.

Maas MB, Rosenberg NF, Kosteva AR, Bauer RM, Guth JC, Liotta EM, Prabhakaran S, Naidech AM.

Neurology. 2013 Jul 9;81(2):107-12. doi: 10.1212/WNL.0b013e31829a33e4. Epub 2013 Jun 5.

42.

Pain, sedation, and delirium management in the neurocritically ill: lessons learned from recent research.

GĂ©linas C, Klein K, Naidech AM, Skrobik Y.

Semin Respir Crit Care Med. 2013 Apr;34(2):236-43. doi: 10.1055/s-0033-1342986. Epub 2013 May 28.

PMID:
23716314
43.

Delayed intraventricular hemorrhage is common and worsens outcomes in intracerebral hemorrhage.

Maas MB, Nemeth AJ, Rosenberg NF, Kosteva AR, Prabhakaran S, Naidech AM.

Neurology. 2013 Apr 2;80(14):1295-9. doi: 10.1212/WNL.0b013e31828ab2a7. Epub 2013 Mar 20.

44.

Subarachnoid extension of primary intracerebral hemorrhage is associated with poor outcomes.

Maas MB, Nemeth AJ, Rosenberg NF, Kosteva AR, Guth JC, Liotta EM, Prabhakaran S, Naidech AM.

Stroke. 2013 Mar;44(3):653-7. doi: 10.1161/STROKEAHA.112.674341. Epub 2013 Feb 7.

PMID:
23391854
45.

Leukoaraiosis on magnetic resonance imaging correlates with worse outcomes after spontaneous intracerebral hemorrhage.

Caprio FZ, Maas MB, Rosenberg NF, Kosteva AR, Bernstein RA, Alberts MJ, Prabhakaran S, Naidech AM.

Stroke. 2013 Mar;44(3):642-6. doi: 10.1161/STROKEAHA.112.676890. Epub 2013 Feb 7.

PMID:
23391853
46.

Coagulopathy disproportionately predisposes to lobar intracerebral hemorrhage.

Maas MB, Rosenberg NF, Kosteva AR, Prabhakaran S, Naidech AM.

Neurocrit Care. 2013 Apr;18(2):166-9. doi: 10.1007/s12028-012-9814-x.

PMID:
23299219
47.

Re: Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality.

Naidech AM, Maas MB, Liotta EM, Guth JC, Bauer RM, Garg RK, Schuele SU, Bleck TP.

Neurocrit Care. 2013 Apr;18(2):285-6. doi: 10.1007/s12028-012-9811-0. No abstract available.

PMID:
23283600
48.

tPA and warfarin: time to move forward.

Alberts MJ, Naidech AM.

Neurology. 2013 Feb 5;80(6):514-5. doi: 10.1212/WNL.0b013e31827b1b7c. Epub 2012 Dec 5. No abstract available.

PMID:
23223535
49.

Anemia and transfusion after aneurysmal subarachnoid hemorrhage.

Rosenberg NF, Koht A, Naidech AM.

J Neurosurg Anesthesiol. 2013 Jan;25(1):66-74. doi: 10.1097/ANA.0b013e31826cfc1d. Review.

PMID:
23047622
50.

Ischemic brain injury after intracerebral hemorrhage: a critical review.

Prabhakaran S, Naidech AM.

Stroke. 2012 Aug;43(8):2258-63. doi: 10.1161/STROKEAHA.112.655910. Epub 2012 Jul 19. Review. No abstract available.

PMID:
22821611

Supplemental Content

Loading ...
Support Center